<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04969822</url>
  </required_header>
  <id_info>
    <org_study_id>1571 - VISA</org_study_id>
    <nct_id>NCT04969822</nct_id>
  </id_info>
  <brief_title>eValuating iDA Selection Ability. The VISA Study.</brief_title>
  <official_title>Will Embryo Selection Through Use of Artificial Intelligence (iDA) Perform Equally Compared to Day 5 Morphology?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vitrolife</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vitrolife</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A non-inferiority, prospective parallel group, multi-center, randomized controlled trial to&#xD;
      investigate whether selection of a single blastocyst for transfer using the deep learning&#xD;
      tool, iDA, results in an equally as high clinical pregnancy rate compared to trained&#xD;
      embryologists using standard morphology criteria.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 20, 2020</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>After 7-9 weeks of gestation</time_frame>
    <description>Ultrasound evidence of an intrauterine pregnancy with a fetal heart observed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>9 months</time_frame>
    <description>Birth of a living child</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive hCG rate per randomized patient</measure>
    <time_frame>Tested on day 9-13 following embryo transfer</time_frame>
    <description>An hCG measurement using urinary sticks with a sensitivity of 25 IU/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of non-viable intrauterine pregnancies</measure>
    <time_frame>After 7-9 weeks of gestation</time_frame>
    <description>Ultrasound evidence of an intrauterine pregnancy but with no fetal heart observed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ongoing pregnancy rate in patients with maternal age above 35</measure>
    <time_frame>After 7-9 weeks of gestation</time_frame>
    <description>Ultrasound evidence of an intrauterine pregnancy with a fetal heart observed</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1040</enrollment>
  <condition>IVF</condition>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Embryo selection by standard morphologic criteria</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The embryo for transfer will be selected by the embryologist on the basis of the morphologic appearances on day 5, according to the Gardner criteria using the ranking guideline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Embryo selection by iDA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Time-lapse videos will be analyzed by iDA and the embryo for fresh transfer on day 5 will be prioritized on the strict basis of the embryo with the highest iDA score. For a frozen cycle; the first embryo to be warmed will be the one with the highest iDA score.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>iDAScoreÂ®</intervention_name>
    <description>A system that studies time lapse images obtained from the embryo culture system, Embryoscope, throughout the development to blastocyst. The system uses data acquired from a sequence of embryo images and has taught itself to identify the embryos with the highest likelihood of implanting and leading to fetal heart-beat detection.</description>
    <arm_group_label>Embryo selection by iDA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Women undergoing IVF or ICSI with controlled ovarian stimulation with gonadotrophins&#xD;
             and the intention to treat by either transfer of a single fresh embryo on day 5 or in&#xD;
             case of a freeze all cycle, the first rewarmed embryo.&#xD;
&#xD;
          2. Age: Up to and including the 42nd completed birthday on the day of randomization.&#xD;
&#xD;
          3. Has at least two early blastocysts on day 5.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Treatment involving donated eggs&#xD;
&#xD;
          2. Intention to perform any form of preimplantation genetic testing&#xD;
&#xD;
          3. The use of IMSI or polarized light in the ICSI process&#xD;
&#xD;
          4. The use of assisted hatching prior to randomization&#xD;
&#xD;
          5. Previous participation in this RCT&#xD;
&#xD;
          6. Where the cycle is carried out for fertility preservation&#xD;
&#xD;
          7. If a day 2-4 transfer is planned&#xD;
&#xD;
          8. Has a reduced likelihood of obtaining two early blastocysts on day 5 as evidenced by&#xD;
             either: an AMH level of &lt;3pmol/L or AFC &lt;5 (if available)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Illingworth, A/Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virtus Health, Sydney, Australia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thorir Hardarson, PhD</last_name>
    <phone>+46708228063</phone>
    <email>thardarson@vitrolife.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>IVFAustralia Greenwich</name>
      <address>
        <city>Sydney</city>
        <state>Greenwich</state>
        <zip>2065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>IVFAustralia Alexandria</name>
      <address>
        <city>Alexandria</city>
        <state>New South Wales</state>
        <zip>2015</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>IVFAustralia, Westmead</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Gardner, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queensland Fertility Group (QFG)</name>
      <address>
        <city>Benowa</city>
        <state>Queensland</state>
        <zip>4217</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Melbourne IVF</name>
      <address>
        <city>East Melbourne</city>
        <state>Victoria</state>
        <zip>3002</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Aagaard Fertilitetsklinik</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>VivaNeo Stork Fertilitetsklinik</name>
      <address>
        <city>Copenhagen</city>
        <zip>1264</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Semmelweis University</name>
      <address>
        <city>Budapest</city>
        <zip>1088</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Livio Fertilitetscentrum</name>
      <address>
        <city>Gothenburg</city>
        <zip>412 55</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Reproductive medicine, Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <zip>413 46</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Thames Valley Fertility (TFP)</name>
      <address>
        <city>Maidenhead</city>
        <zip>SL6 4BY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nurture Fertility (TFP)</name>
      <address>
        <city>Nottingham</city>
        <zip>NG10 5QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Oxford Fertility (TFP)</name>
      <address>
        <city>Oxford</city>
        <zip>OX4 2HW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Wessex Fertility (TFP)</name>
      <address>
        <city>Southampton</city>
        <zip>SO15 5QS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Denmark</country>
    <country>Hungary</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 30, 2021</study_first_submitted>
  <study_first_submitted_qc>July 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2021</study_first_posted>
  <last_update_submitted>July 9, 2021</last_update_submitted>
  <last_update_submitted_qc>July 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Embryo</keyword>
  <keyword>Embryo scoring</keyword>
  <keyword>Blastocyst selection</keyword>
  <keyword>Pregnancy rate</keyword>
  <keyword>Live birth rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

